Hi everyone,
I don’t know if everyome has seen that the UK has approved a new treatment, elranatamab, as fourth line or subsequent treatment.
Elranatamab approved at fourth line and beyond
Elranatamab is a bispecific antibody, and is as far as I know the first bispecific antibody approved in the UK.
It is far from a panacea, with high risks of infection, but it is still great news.
Regards
Rabbit
